Evidence map›Paper›PMID 10727212›Full record

ArticleBiochemistry2000

Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.

K L Jordan-Sciutto, J M Dragich, J Caltagarone, D J Hall, R Bowser

Abstract read
In one paragraph

Article in Biochemistry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K L Jordan-SciuttoDepartments of Pathology and Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
J M Dragich
J Caltagarone
D J Hall
R Bowser
Thomas Jefferson University · USUniversity of Pittsburgh · US

Funding

TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LINGLER, JENNIFER HAGERTY · 1985 to 2019
$43.0M
NOVEL ANTIGEN IN DEVELOPING BRAIN AND ALZHEIMERS DISEASER29AG013208 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOWSER, ROBERT P · 1995 to 2000
$113k
MOLECULAR MECHANISMS OF BRAIN DEVELOPMENT AND DISEASEF32NS010572 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JORDAN-SCIUTTO, KELLY L · 1997 to 1998
–
NIA NIH HHS AG05133NIA NIH HHS AG13208NIA NIH HHS P50 AG005133NINDS NIH HHS F32 NS010572NINDS NIH HHS NS10572
6 · The paper itself

Abstract

Transcription factors mediate their regulatory effects through interaction with DNA and numerous nuclear proteins. The fetal Alz-50 clone 1 (FAC1) protein, a novel DNA-binding protein with the capacity to repress transcription, is likely to function through a similar mechanism (1). Using the two-hybrid yeast screen, we have shown that FAC1 interacts with the myc-associated zinc finger protein (ZF87/MAZ). This association was confirmed in vitro with recombinant protein. The ZF87/MAZ interaction domain was mapped to the region containing a putative nuclear localization signal (NLS) and nuclear export sequence (NES) of FAC1, using deletion mutants of the FAC1 protein. FAC1, on the other hand, recognizes a conformational interface that includes the proline/alanine-rich domain of ZF87/MAZ and the first zinc finger. Cotransfection of NIH3T3 cells with ZF87/MAZ and a luciferase reporter containing the SV40 promoter and enhancer results in an increase in transcriptional activation, suggesting ZF87/MAZ is able to recognize its consensus binding site present in the SV40 promoter. Cotransfection with FAC1 reduces the level of ZF87/MAZ-induced activation of the SV40 promoter in a dose dependent manner. A mutant FAC1, lacking the ZF87/MAZ interaction domain, does not alter ZF87/MAZ activation of the SV40 promoter. These data demonstrate that interaction between FAC1 and ZF87/MAZ alters the transactivation capacity of ZF87/MAZ. By immunoblot analysis, FAC1 and ZF87/MAZ exhibit similar tissue distribution and co-localize to pathologic structures in Alzheimer's disease brain. Coexpression of FAC1 and ZF87/MAZ suggest that interaction of these two proteins will have biological implications for gene regulation in neurodegeneration.

Indexed as

Zinc Fingers3T3 CellsAlzheimer DiseaseAnimalsAntigens, NuclearBiological TransportBromodomain Containing ProteinsDNA-Binding ProteinsHumansImmunoblottingMiceNerve Tissue ProteinsNuclear Localization SignalsNuclear ProteinsOrgan SpecificityProto-Oncogene Proteins c-mycAntigens, NuclearBromodomain Containing Proteinsc-MYC-associated zinc finger proteinDNA-Binding Proteinsfetal Alzheimer antigenNerve Tissue ProteinsNuclear Localization SignalsNuclear ProteinsProto-Oncogene Proteins c-mycRepressor ProteinsTranscription Factors

Identifiers

PMID10727212
PMCPMC3667205
OpenAlexW2001322117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.